Group d1 Topic 3 PET
Group d1 Topic 3 PET
Group d1 Topic 3 PET
College of Medicine
Supervised by
Dr. Ramaq Al-Qadhi
Lec. Dalya Al-Eqabi
Objectives:
• What is PET?
1
• PET history
• Main system components
• Principle of PET
• Image Acquisition
• Image reconstruction
• PET facility configuration
• Clinical applications of PET
• Pros and cons
• PET/CT principles and applications of PET/CT
• PET radiopharmaceuticals
• FDG
What is PET?
Positron Emission Tomography (PET) is at present one of the most
technologically advanced diagnostic methods for non-invasive imaging in
medicine.
2
It plays a unique role both in medical diagnostics and in monitoring effects
of therapy, in particular in oncology, cardiology, neurology and psychiatry.
In PET measurement the patient is injected with radiotracer, containing a
large number of metastable atoms of positron emitting radionuclide.
As the result of positron annihilation, two photons travelling off with nearly
opposite directions are produced. The detection system is usually arranged
in layers forming a ring around the diagnosed patient.
History of PET:
The first demonstration of PET technique for medical imaging use was
given in early 1950s by Brownell and Burnham. This was an inspiration for
the concept of emission tomography used to visualize functional processes
in the body in the late 1950s. The first 3-dimensional PET detector, called
3
PC-1, was developed at the Massachusetts General Hospital and completed
in 1969.
Drs. Brownell (left) and Aronow are shown with scanner (1953).
4
surrounds the patient. It consists of multiple detector that are designed to
detect the gamma rays.
2. Patient bed: The patient bed is where the patient lies during the
scanning process
6. Computer system and software: it acts as the central processing unit for
the PET system. It converts the acquired data and generates detailed
images of the patient's body.
Principle of PET:
-PET uses radiotracer or pharmaceutical fluoro deoxy-glocuse (FDG).
-Firstly, FDG is injected intravenously into the patient.
-FDG emits positron by going into the patient abnormalities or malignance
tissue.
-The half-life of positron is very short.
5
-Glucose molecule by metabolism become Gloucose-6 phosphate.
-FDG is similar to our glucose molecule and travels in the body same way
as glucose and undergoes metabolism.
-FDG is metabolized into FDG-6 phosphate by Hexokinase.
-if the tissue is normal, this process continues during the metabolism.
-if there is any malignance, presence of pathology, infection or other
abnormalities, the FDG gets trapped.
-FDG emits positron from abnormal tissue.
-The emitted positron joins (interact) With an electron and undergoes
annihilation.
-The positron annihilation produces 2 photons of energy each emitted in
opposite direction (180 degree) in the body site.
-These photons are detected by a set of ring detectors surrounding the
patient.
-The detector sends these signals to the computer and the computer
creates the final image from these signals.
Image acquisition is
an action of retrieving
image from an external
source for further
processing because it's
6
completely unprocessed, It's the foundation step in the workflow since no
process is available before obtaining an image. The three steps of image
acquisition are Energy reflected from the thing of interest, an optical
system that focuses the energy and lastly a sensor that measures the
quantity of energy. The most common and basic sensor for image
acquisition is a photodiode which is constructed of silicon materials so its
output voltage is proportional to incoming light.
-Since in a PET system the object is placed in the scanner, the scintillator
ring can detect extremely low signal, the signal consists of a single
positron, so each detector element is quite large.
7
-Recent advances in technology have enabled smaller and smaller elements
in this array which in turn leads to better resolution. The use of cascade
photo diodes to replace the scintillator ring also increases the speed of
acquisition that will in turn increase resolution.
-In PET imaging a radio tracer is injected and once this binds with the
target tissue a collision event occurs, resulting in two positrons being
emitted in opposite directions to each other at the speed of light and hit
the detector ring simultaneously, so the scanner records a CO-INCIDENCE
event frequently. Time scale over this happens is depended on the tracers
binding potential and the abundance of what is being bound but typically is
between 6 and 12 nanoseconds.
-Then the output data from the scanner is a series of points that represents
the coincidence events, each event is represented as two points through
which a line can be drawn called LINE OF RESPONSE or LOR. As we add
more of the events, the result is a final probabilistic map of the source of
the events. The most typically used techniques of this involves first sorting
the LORs into similar directions, grouping them into sonograms and then
reconstructing them as per CT back projection.
8
1. PET Scanner Room: This is where the PET scanner is located. The room
is designed to shield external interference and provide a controlled
environment for imaging.
5. Control Room: Operators control and monitor the PET scanner from this
room, ensuring the imaging process runs smoothly.
6. Storage and Waste Disposal: Safe storage for radiotracers and proper
disposal systems for radioactive waste are essential.
9
1. Oncology: PET is widely used in cancer diagnosis, staging, and
treatment planning. It helps visualize and quantify metabolic activity, aiding
in the detection of tumors and assessment of their response to treatment.
10
8. Pediatrics: In pediatric oncology, PET assists in tumor detection, staging,
and treatment monitoring. It is also used in certain neurological and
inflammatory conditions in children.
11
3-Distinguish between benign and malignant tumors-reducing unnecessary
surgeries due to misdiagnosis.
Cons:
1-lonizing radiation
12
- Coregistration of PET scans with CT using a combined PET-CT
scanner improves the overall sensitivity and specificity of information
provided by PET or CT alone.
PET radiopharmaceuticals:
radiopharmaceuticals, which are drugs labeled with a small amount of
radioisotope to detect and measure the distribution and metabolism
of these compounds in the body.
14
FDG
As we know PET is special imaging technique used in nuclear medicine this
technique based on measurements of positron emission from Radio_labelled
tracer molecules.
it means PET Scan uses radiotracer injected into the patient before the scan to
visualize the blood flow, metabolic & biochemical activities in diseased &
healthy tissue.
FDG is a glucose analogue that tend to accumulate in the tissue with high
Glucose demand like tumors & inflammatory cells.
So the most common R-tracer used today is (18F - FDG).
15
image with 18F- FDG → determine abnormal glucose metabolism sites
that characterize (describe) & localize (determine location)
the tumors.
FDG mechanism
→ The patient gets an injection or is injected with Radio-active Sugar
(FDG-18)
→ Cells absorb sugar.
→ Area using more energy pick more Sugar.
→ Cancer Cells Use or consume more energy than healthy Cells.
Because cancer cells have a highly glycolysis rate leading to increase transport
& accumulation of FDG into these cells compared to healthy cells.
→ PET Scan detect this accumulation due to the radioactive decay of fluorine-
18 which lead to radioactive emission.
→ The emission Source in FDG is fluorine 18 which has a life time about 10
min. when it decays the nucleus of 18F emits a positron. Collides with electron.
→ Collision result in annihilation.
→ annihilation leading to conversion of mass
16
into energy.
→ This energy will be in form of two photons.
→ The scintillation crystals in the PET cameras absorb energy from photons
& emit light into electrical signals.
REFERENCES:
17
18